Other Ways to Achieve Metabolic Control
|
|
- Dorcas Hutchinson
- 5 years ago
- Views:
Transcription
1 Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department of Surgery University of Miami Miller School of Medicine Miami, Florida
2 STANDARDS OF MEDICAL CARE IN DIABETES 2012
3 Recommendations: Bariatric Surgery Consider bariatric surgery for adults with BMI >35 kg/m 2 and type 2 diabetes (B) After surgery, life-long lifestyle support and medical monitoring is necessary (B) Insufficient evidence to recommend surgery in patients with BMI <35 kg/m 2 outside of a research protocol (E) Well-designed, randomized controlled trials comparing optimal medical/lifestyle therapy needed to determine long-term benefits, costeffectiveness, risks (E) ADA. V. Diabetes Care. Diabetes Care 2012;35(suppl 1):S27.
4 4
5 5
6 6
7 Bariatric Surgery A Systematic Review and Meta-analysis Impact of Bariatric Surgery on Diabetes TOTAL* GASTRIC BYPASS OUTCOME t (n/n) % [95%CI] t (n/n) % [95% CI] % Patients Diabetes Resolved 63 (1,846) 76.8 [70.7, 82.9] 26 (989) 83.7 [77.3, 90.1] HbA1C (%) Reduction (Diabetics)** 6 (171) -2.4 [-3.8, -1.0] 4 (88) -3.0 [-5.0, -1.1] Fasting Glucose (mmol/l)** 14 (296) -4.0 [-5.2, -2.7] 7 (164) -3.4 [-5.2, -1.7] Fasting Insulin (pmol/l)** 36 (1,460) [ ] 6 (93) [ ] Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery Systematic Review of the Literature and Meta-analysis. Journal of the American Medical Association 2004 Oct 13;292(14).
8 Bariatric Surgery Systematic Review and Meta-analysi Impact of Bariatric Surgery on Hypertension TOTAL* GASTRIC BYPASS OUTCOME t (n/n) % [95%CI] t (n/n) % [95% CI] Patients Hypertension Resolved 67 (4,805) 61.7 [55.6, 67.8] 20 (2,115) 67.5 [58.4, 76.5] * Total All bariatric procedures including gastric bypass surgery, Vertical Banded Gastroplasty (VBG), Laparoscopic Adjustable Gastric Banding, Biliopancreatic Diversion, and Duodenal Switch. t = number of studies or treatment groups; n = number of patients with this characteristic; N = number of patients evaluated; Hypertension resolved numerator = discontinued treatment or condition disappeared; denominator includes patients evaluated for resolution. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery A Systematic Review of the Literature and Meta-analysis. Journal of the American Medical Association 2004 Oct 3;292(14).
9 Bariatric Surgery A Systematic Review and Meta-analysis Impact of Bariatric Surgery on Hyperlipidemia TOTAL* GASTRIC BYPASS OUTCOME t (N) % [95%CI] t (n/n) % [95% CI] % Patients Improved Hyperlipidemia 23 (846/1,019) 79.3 [68.2, 90.5] 6 (125) 96.9 [93.6, 100.0] Hypercholesterolemia 14 (2,051) 71.3 [55.5, 87.0] 5 (439) 94.9 [90.7, 99.1] Hypertriglyceridemia 11 (983) 82.4 [71.1, 93.7] 4 (271) 91.2 [83.6, 98.8] * Patients Improved numerator includes patients described by study authors as having improved by virtue of elimination or reduction in therapy and patients reported to have improved lipid parameters. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery A Systematic Review of the Literature and Meta-analysis. Journal of the American Medical Association 2004 Oct 13;292(14).
10 RYGB and Type 2 Diabetes Authors Pories WJ, Swanson MS, MacDonald KG, et al 1995;222: % of type 2 diabetic subjects euglycaemic up to 14 yrs follow-up
11 Long-term mortality after gastric bypass surgery Compared long-term mortality among 7,925 US patients undergoing gastric bypass surgery between 1994 and 2002 and the same number of matched controls with severe obesity. Deaths were assessed using the National Death Index at a mean follow-up of 7 years. Adams TD, Gress RE, Smith SC, et al. N Engl J Med 2007;357:
12 Long-term mortality after gastric bypass surgery Results At 5 year follow-up, gastric bypass was associated with a 40% reduction in the risk of death from any cause. Disease specific mortality reductions Coronary artery disease 56% Diabetes 92% Adams TD, Gress RE, Smith SC, et al. N Engl J Med 2007;357:
13 Laparoscopic Gastric Bypass Surgery and Adjustable Gastric Banding Significantly Decrease the Prevalence of Type 2 Diabetes Mellitus and Pre-Diabetes among Morbidly Obese Multiethnic Adults: Long-Term Outcome Results Nestor de la Cruz- Muñoz, MD, FACS 1 Sarah E. Messiah, Ph.D., M.P.H. 2 Kristopher L. Arheart, Ed.D. 2,3 Gabriela Lopez-Mitnik, M.S. 2 Steven E. Lipshultz, M.D. 2,3 Alan Livingstone, M.D., F.A.C.S. 1 1 DeWitt Daughtry Family Department of Surgery 2 Department of Pediatrics, Division of Pediatric Clinical Research; 3 Department of Epidemiology and Public Health University of Miami Miller School of Medicine Miami, Florida
14 Methods A retrospective ( ) medical chart analysis of 1,603 adults 77% female 66% Hispanic mean age at surgery 45 yrs Pre- and 6-month, 1-, 2-, and 3-year post surgery comparative means analyses of: weight (kg) -EWL -BMI HbA1c -FPG
15 Study Sample 377 subjects had T2DM (determined by previous diagnosis and/or medication usage) 107 had a fasting plasma glucose [FPG] 126 mg/dl but were not on medication and were labeled as undiagnosed T2DM 276 were pre-diabetic (FPG= mg/dl) 843 had a normal FPG pre-surgery
16 Pre-Surgery Characteristics * Fasting glucose 126 mg/dl and not on medication for T2DM. Fasting glucose mg/dl.
17 Body Mass Index BMI score Baseline 6 Months 1 Year 2 Years 3 Years Diabetic Pre Diabetic Undiagnosed Diabetic Normal Glucose 17
18 Fasting Glucose and Hemoglobin A1c Changes from Pre-Post Surgery * Fasting glucose 126 mg/dl and not on medication for T2DM. Fasting glucose mg/dl
19 19
20 Fasting Glucose mg/dl Baseline 6 Months 1 Year 2 Years 3 Years Diabetic Pre Diabetic Undiagnosed Diabetic Normal Glucose 20
21 Conclusions Bariatric surgery results in significant weight loss and improvement in FPG and HbA1c levels as far as 3-years post-surgery among ethnically-diverse adults. Bariatric surgery is a safe and effective option for weight and chronic disease risk improvements in this demographic.
22 Laparoscopic Roux-en-Y Gastric Bypass Procedure Reverses the Metabolic Syndrome in Multiethnic Adults N. de la Cruz-Muñoz 1, G. Lopez-Mitnik 2, K.L. Arheart 3, S.E. Lipshultz 2,3, S.E. Messiah 2,3 1Department of Surgery, 2 Department of Pediatrics, 3Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL; Retrospective chart analysis 314 adults (82% female, mean age years, SD 10.9 years) Pre- and 1-yr post surgery change in MetS status was assessed via generalized estimating equation (GEE) models. MetS prevalence 43% pre to 10% post (P<0.0001) Men 53% pre- to 12% Women 40% pre- to 11% (P< for both comparisons). Non-Hispanic blacks (64% to 17%) Hispanics (44% to 12%) Non-Hispanic whites (22% to 7%)
23 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Objective To determine if surgically induced weight loss results in better glycemic control and less need for diabetes medications than conventional approaches to weight loss and diabetes control. Dixon JB, et al. JAMA. 2008;299(3):
24 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Design, Setting, and Participants randomized controlled trial conducted from December 2002 through December 2006 Participants were 60 obese patients (BMI >30 and <40) with recently diagnosed (<2 years) type 2 diabetes. Interventions Conventional diabetes therapy with a focus on weight loss by lifestyle change vs laparoscopic adjustable gastric banding with conventional diabetes care. Dixon JB, et al. JAMA. 2008;299(3):
25 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Main Outcome Measures Remission of type 2 diabetes (fasting glucose level <126 mg/dl [7.0 mmol/l] and glycated hemoglobin [HbA1c] value <6.2% while taking no glycemic therapy). Secondary measures included weight and components of the metabolic syndrome. Analysis was by intention-to-treat. Dixon JB, et al. JAMA. 2008;299(3):
26 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Dixon JB, et al. JAMA. 2008;299(3):
27 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Dixon JB, et al. JAMA. 2008;299(3):
28 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial 73% vs 13% Remission of type 2 diabetes FBG <126 mg/dl and HbA1c value <6.2% while taking no glycemic therapy Dixon JB, et al. JAMA. 2008;299(3):
29 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Use of Nondiabetes Medication Reduction in use of antihypertensive agents Surgical group (20/29 at baseline and 6/29 at 2 years, P <.001) Conventional-therapy group (15/26 at baseline and at 2 years) (P =.005) Reduction in the use of lipid-lowering medications Surgical group (12/29 at baseline and 4/29 at 2 years, P =.02) Conventional-therapy group (8/26 at baseline and 7/26 at 2 years). Dixon JB, et al. JAMA. 2008;299(3):
30 Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes A Randomized Controlled Trial Conclusions superior glycemic control and diabetes remission rates, higher rates of resolution of metabolic syndrome improvements in insulin sensitivity and concentrations of trig and HDL chol degree of weight loss, not the method, appeared to be the major driver of glycemic improvement and diabetes remission Dixon JB, et al. JAMA. 2008;299(3):
31 Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program RCT 80 adults (20-50yo) BMI 30-35kg/m 2 with associated comorbidity Outcome measures were weight change, presence of the metabolic syndrome, and change in quality of life at 2 years O Brien PE, et al. Annals of Internal Medicine. 2006;144 (9)
32 Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program Nonsurgical Program This program centered on the use of behavioral modification, very-low-calorie diet, and pharmacotherapy with education and professional support began with an intensive 6-month period of very-low-calorie diet A physician saw each patient every 2 weeks during the very- low-calorie diet program and every 4 to 6 weeks during the rest of the study. All patients were seen at least every 6 weeks. O Brien PE, et al. Annals of Internal Medicine. 2006;144 (9)
33 Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program % Weight Loss O Brien PE, et al. Annals of Internal Medicine. 2006;144 (9)
34 Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program O Brien PE, et al. Annals of Internal Medicine. 2006;144 (9)
35 Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program O Brien PE, et al. Annals of Internal Medicine. 2006;144 (9)
36 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes randomized, controlled trial: 60 patients (30-60 yo) BMI 35 a history of at least 5 years of diabetes, HgA1c 7.0% conventional medical therapy vs. gastric bypass or biliopancreatic diversion Primary end point: Rate of diabetes remission at 2 years defined as a fasting glucose level of <100 mg/dl and HgA1c <6.5% in the absence of pharmacologic therapy). Mingrone G, et al. N Engl J Med ;17 36
37 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes Medical Therapy a multidisciplinary team visits at baseline and at 1, 3, 6, 9, 12, and 24 mo reduced overall energy and fat intake (<30% total fat, <10% sat. fat, and high fiber) increased physical exercise ( 30 minutes of brisk walking every day, possibly associated with moderate-intensity aerobic activity twice a week Mingrone G, et al. N Engl J Med ;17 37
38 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes Mingrone G, et al. N Engl J Med ;17 38
39 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes At 2 years, DM remission: in none of medical therapy, 15 of 20 (75%) of gastric bypass and 19 of 20 (95%) of biliopancreatic diversion (P<0.001 for both comparisons). Mingrone G, et al. N Engl J Med ;17 39
40 Mingrone G, et al. N Engl J Med ;17 40
41 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes Mingrone G, et al. N Engl J Med ;17 41
42 Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes In conclusion, our findings indicate that bariatric surgery, specifically gastric bypass and biliopancreatic diversion, may be more effective than conventional medical therapy in controlling hyperglycemia in severely obese patients with type 2 diabetes. Mingrone G, et al. N Engl J Med ;17 42
43 BPD in lean humans Chylomichronemia Diabetes Preop BMI: Results: No weight loss No changes in eating behaviour Remission of diabetes Normalization of plasma lipid profile Increase in BMI levels over time (24-26) Mingrone et al. Diabetologia 1992
44 BPD and Type 2 Diabetes 312 BPD obese patients with type 2 diabetes Fasting glucose fell within normal values in 310/312 pts 10 years after surgery 304/310 patients maintained normal fasting glucose levels
45 Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes randomized, controlled trial: 150 patients (20-60 yo) BMI a history uncontrolled diabetes, HgA1c 7.0% Intensive medical therapy vs. gastric bypass or sleeve gastrectomy Primary end point: proportion of patients with a HgA1c 6.0% 12 months after treatment. Secondary end points: levels of fasting plasma glucose, fasting insulin, lipids, and high-sensitivity C-reactive protein; the homeostasis model assessment of insulin resistance (HOMA-IR) index; weight loss; blood pressure; adverse events; coexisting illnesses; and changes in medications. Schauer P, et al. N Engl J Med ;17 45
46 Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes Schauer P, et al. N Engl J Med ;17 46
47 Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes Schauer P, et al. N Engl J Med ;17 47
48 Schauer P, et al. N Engl J Med ;17 48
49 Schauer P, et al. N Engl J Med
50 Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes Conclusions We conclude that bariatric surgery represents a potentially useful strategy for management of uncontrolled diabetes, since it has been shown to eliminate the need for diabetes medications in some patients and to markedly reduce the need for drug treatment in others. In addition, among patients undergoing surgery, cardiovascular risk factors improved, allowing reductions in lipid-lowering and antihypertensive therapies. Schauer P, et al. N Engl J Med ;17 50
51 Bariatric Surgery in Non Morbidly Obese Patients 37 Pts BMI Resolution in all
52 Duodenal-Jejunal Bypass (DJB)
53
54 Duodeno-Jejunal Bypass R Cohen et.al SOARD, 2007 First in Man Duodenal Jejunal Bypass HbA 1c (%) BMI (kg/m2) Time Post Surgery (month) Time Post Surgery (month)
55
56
57
58 Other Approaches Ileal Transposition DePaula
59 First in Man Ileal Transposition & Sleeve Gastrectomy Glycemic Results (18.8 months mean followup) A1c Post-Prandial Glucose Pre-op Post-op 0 Pre-op Post-op A depaula and A Macedo; US Endocrine Review; Spring 2007: 43-48
60 First in Man Ileal Transposition & Sleeve Gastrectomy Metabolic Results (Mean weight loss - 24 ± 9%) Triglycerides HDL Pre-op Post-op 0 Pre-op Post-op A depaula and A Macedo; US Endocrine Review; Spring 2007: 43-48
61 New Procedure (for the Non-obese) Omentectomy Midgut Entrectomy Leaving the first 40cm of jejunum and the last 260cm of ileum. Sérgio Santoro; Preliminary Report. Adaptive entero-omentectomy: Physiological and evolutionary bases of an auxiliary treatment to type 2 diabetes. Einstein 2004;2(3)193-8
62
63 Conclusions Bariatric surgery can put T2DM into remission and can resolve metabolic syndrome in some obese patients Consider bariatric surgery as a treatment option for adults with BMI >35 kg/m 2 and type 2 diabetes and/or metabolic syndrome (some would say earlier rather then later) We may soon be considering surgery in patients with BMI <35 kg/m 2 with uncontrolled DM 63
6/10/2016. Bariatric Surgery: Impact on Diabetes and CVD Risk. Disclosures BARIATRIC PROCEDURES
Bariatric Surgery: Impact on Diabetes and CVD Risk Anthony M Gonzalez, MD, FACS, FASMBS Medical Director Bariatric Surgery, South Miami Hospital Chief of Surgery, Baptist Hospital of Miami Associate Professor
More informationA Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications
A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications Shahzeer Karmali MD FRCSC FACS Associate Professor Surgery University of Alberta
More informationtype 2 diabetes is a surgical disease
M. Lannoo, MD, University Hospitals Leuven Walter Pories claimed in 1992 type 2 diabetes is a surgical disease Buchwald et al. conducted a large meta-analysis THE FIRST OBSERVATIONS W. Pories 500 patients
More informationCurrent Trends in Bariatric Surgery
Current Trends in Bariatric Surgery 9.28.2017 Abraham Krikhely, MD, FACS, FASMBS Assistant Professor of Surgery, CUMC Center of Minimal Access, Metabolic and Weight Loss Surgery Outline Why consider surgery
More informationEffect of Bariatric Surgery on Cardio-Metabolic Outcomes
Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Disclosure Research support from Bariatric Advantage (supplements donated for research study) Anne Schafer, MD Associate Professor of Medicine and
More informationBariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,
More informationThe Changing Shape of Bariatric Surgery
Measuring Obesity The Changing Shape of Bariatric Surgery D. Scott Diamond, MD FACS Determined by height and weight Comparison to ideal body weight/height BMI = weight(kg) height(m) 2 BMI = weight(lb)*
More informationObesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.
Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link
More information* Assit. prof., *** Prof. & Head of deptt., Deptt. of Surgery, MGIMS ** Asstt prof Deptt. of Medicine. REVIEW ARTICLE
REVIEW ARTICLE TYPE 2 DIABETES MELLITUS - EXPLORING THE AVENUE OF BARIATRIC SURGERY. S RAO*, JAIN VV**, GUPTA DO***. Diabetes is a growing public health problem world-wide and especially in India which
More informationBARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS
BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS George Vl Valsamakis European Scope Fellow Obesity Visiting iti Associate Prof Warwick Medical School Diabetes is an increasing healthcare epidemic throughout
More information3. Metabolic Surgery and Control of Type 2 Diabetes
3. Metabolic Surgery and Control of Type 2 Diabetes Philip R. Schauer, MD Shai M. Eldar, MD Helen M. Heneghan, MD Stacy A. Brethauer, MD The rising prevalence of obesity, coupled with disappointing results
More informationNew insights in metabolic surgery
New insights in metabolic surgery G.Hubens 11th Starters Package Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes W Pories 1995 222: 339-350 KEY
More informationLaparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type II Diabetes Mellitus in Chinese Patients with Body Mass Index of 25 35
OBES SURG (2011) 21:1344 1349 DOI 10.1007/s11695-011-0408-z CLINICAL RESEARCH Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type II Diabetes Mellitus in Chinese Patients with Body Mass Index
More informationTHE WORLD EPIDEMIC OF OVERweight
REVIEW Bariatric Surgery A Systematic Review and Meta-analysis Henry Buchwald, MD, PhD Yoav Avidor, MD Eugene Braunwald, MD Michael D. Jensen, MD Walter Pories, MD Kyle Fahrbach, PhD Karen Schoelles, MD
More informationOBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY
OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest CLASSIFICATION OF OVERWEIGHT
More informationBariatric Surgery Update
Bariatric Surgery Update Alexander Perez, MD, FACS Professor of Surgery Chief, Division Minimally Invasive and Foregut Surgery Speaker Disclosure Dr. Perez has disclosed that the has no actual or potential
More informationDiabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis
OBES SURG (2014) 24:437 455 DOI 10.1007/s11695-013-1160-3 REVIEW ARTICLE Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis
More informationRoux-and-Y Gastric Bypass and its Metabolic Effects
Roux-and-Y Gastric Bypass and its Metabolic Effects Nicola Di Lorenzo President elect of SICOb Italian Society for Bariatric Surgery and Metabolic Diseases Dept. of General Surgery-Università di Roma Tor
More informationCurrent Status of Bariatric Surgery in Asia
Emerald hall A, 1:2-1:5, November 7, 213 Current Status of Bariatric Surgery in Asia Go Wakabayashi, MD, PhD, FACS Professor and Chairman Department of Surgery Iwate Medical University Numbers of bariatric
More informationTreating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition
Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with
More informationDisclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None
Disclosures None OBESITY Florencia Halperin, M.D. Medical Director, Program for Management Brigham and Women s Hospital Instructor in Medicine, Harvard Medical School Overview Obesity: Definition Definition
More informationChoice Critria in Bariatric Surgery. Giovanni Camerini
Choice Critria in Bariatric Surgery Giovanni Camerini Surgical vs Medical treatment Indications for Bariatric Surgery (WHO 1992) BMI of at least 40; BMI of 35 in case of serious diseases related to obesity;
More informationSURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS
SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS Professor of Surgery Vice-Chairman Department of Surgery Florida International University Herbert Wertheim College of Medicine
More informationBariatric surgery: has anything changed in the last few years?
Bariatric surgery: has anything changed in the last few years? Mauro Toppino University of Turin Digestive and Colorectal Surgery Minimal Invasive Surgery Center (Head:Prof. Mario Morino) XIV Annual Conference
More informationJAMA February 10, 2010 Laparoscopic Adjustable Banding in Severely Obese Adolescents: A Randomized Trial
JAMA February 10, 2010 Laparoscopic Adjustable Banding in Severely Obese Adolescents: A Randomized Trial Daniel DeUgarte, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program Bariatric
More informationWhat s New in Bariatric Surgery?
Bariatric Surgery: Update for the General Surgeon What s New in Bariatric Surgery? 2,000 B.C. 2,000 A.D. 1. America keeps getting fatter without an end in sight. 2. Bariatric surgery is not just about
More informationCME Post Test. D. Treatment with insulin E. Age older than 55 years
CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/
More informationBariatric Surgery: The Primary Care Approach
The 8 th Annual Conference of the Lebanese Society of Family Medicine October 25 th 2009 Bariatric Surgery: The Primary Care Approach Bassem Y. Safadi, MD, FACS Associate Professor of Clinical Surgery
More informationImpact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore
Singapore Med J 2013; 54(7): 382-386 doi: 10.11622/smedj.2013138 Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore Phong Ching Lee 1,3, MBChB, MRCP, Kwang Wei Tham
More information2/10/2014 CARDIOVASCULAR BENEFITS OF BARIATRIC SURGERY. Disclosures. My Background
CARDIOVASCULAR BENEFITS OF BARIATRIC SURGERY Anthony M Gonzalez, MD, FACS, FASMBS Associate Professor of Surgery, FIU College of Medicine Chief of Surgery, Baptist Hospital of Miami Medical Director Bariatric
More informationBariatric Surgery and Bone Health
Bariatric Surgery and Bone Health No conflicts of interest Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism July 26, 202 BMI and Fracture Risk Low BMI is associated
More informationMULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS
Bariatric endoscopy MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS Marek Benes, Tomas Hucl, Pavel Drastich, Julius
More informationPredictors of Short-Term Diabetes Remission After Laparoscopic Roux-en-Y Gastric Bypass
Predictors of Short-Term Diabetes Remission After Laparoscopic Roux-en-Y Gastric Bypass Gianluca Iacobellis, Chengyu Xu, Rafael E. Campo & Nestor F. De La Cruz- Munoz Obesity Surgery The Journal of Metabolic
More informationBariatric Surgery and Diabetes: Implications of Type 1 Versus Insulin-Requiring Type 2
Bariatric Surgery and Diabetes: Implications of Type 1 Versus Insulin-Requiring Type 2 Spyridoula Maraka 1, Yogish C. Kudva 1, Todd A. Kellogg 2, Maria L. Collazo-Clavell 1, and Manpreet S. Mundi 1 Objective:
More informationBariatric Surgery Update
Friday General Session Bariatric Surgery Update Alex Perez, MD Chief, Division of Minimally Invasive and Foregut Surgery James E. Thompson, MD Family Distinguished Professor in Surgical Simulation Co Director,
More informationCommonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital
Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery
More informationSurgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008
Surgical Therapy for Morbid Obesity Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 28 Obesity BMI > 3 kg/m 2 Moderate 35-4 kg/m 2 Morbid >4 kg/m 2 1.7 BILLION Overweight Adults in the world 63 MILLION
More informationAmerican Society for Metabolic & Bariatric Surgery
American Society for Metabolic & Bariatric Surgery April 27, 2012 Louis Jacques, MD Director, Coverage and Analysis Group Centers for Medicare and Medicaid Services Mail Stop S3-02-01 7500 Security Boulevard
More informationTrends in bariatric surgery publications worldwide. Salman Al Sabah, Fatemah Al Marri, Eliana Al Haddad
Trends in bariatric surgery publications worldwide Salman Al Sabah, Fatemah Al Marri, Eliana Al Haddad This is a PDF file of an unedited manuscript that has been accepted for publication. As a service
More informationSurgery for Obesity and Related Diseases 9 (2013) Original article
Surgery for Obesity and Related Diseases 9 (2013) 42 47 Original article Medium-term outcomes of patients with insulin-dependent diabetes after laparoscopic adjustable gastric banding Rishi Singhal, M.R.C.S.*,
More informationBariatric Surgery: A Cost-effective Treatment of Obesity?
Bariatric Surgery: A Cost-effective Treatment of Obesity? Shaneeta M. Johnson MD FACS FASMBS 2018 NMA Professional Development Seminar Congressional Black Caucus Foundation Annual Legislative Conference
More informationAssociate. Professor of. Minimally. Invasive Surgery
Surgical Task Force Recommendations Ken Reed MD, FRSCS Committee Chair, and Staff Surgeon, Guelph General Hospital Clinical Associate Professor of Surgery, McMaster University Dennis Hong MD, MS.c, FRCSC,
More informationType 2 diabetes and metabolic surgery:
Type 2 diabetes and metabolic surgery: Shouldn't we call it again again bariatric? Josep Vidal Obesity Unit. Endocrinology and Nutrition Department Hospital Clínic, University of Barcelona (Spain) What
More informationBenefits of Bariatric Surgery
Benefits of Bariatric Surgery Dr Tan Bo Chuan Registrar, Department of Surgery GP Forum 27 May 2017 Improvements of Co-morbidities Type 2 diabetes mellitus Hypertension Hyperlipidemia Degenerative joint
More informationBariatric Surgery: Indications and Ethical Concerns
Bariatric Surgery: Indications and Ethical Concerns Ramzi Alami, M.D. F.A.C.S Assistant Professor of Surgery American University of Beirut Medical Center Beirut, Lebanon Nothing to Disclose Determined
More informationObesity & Metabolic (Diabetes) Surgery
Obesity & Metabolic (Diabetes) Surgery Sherif Awad PhD, FRCS Consultant Obesity Surgeon & Clinical Lead East-Midlands Bariatric & Metabolic Institute (EMBMI), Derby Teaching Hospitals BARS Conference,
More informationLaparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease
Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease Erik Peltz, D.O. April 7 th, 2008 University of Colorado Health Science Center Department
More informationViriato Fiallo, MD Ursula McMillian, MD
Viriato Fiallo, MD Ursula McMillian, MD Objectives Define obesity and effects on society and healthcare Define bariatric surgery Discuss recent medical management versus surgery research Evaluate different
More informationLong-Term Follow Up: The Burning Platform
Long-Term Follow Up: The Burning Platform John Morton, MD, MPH, FACS, FASMBS Chief, Bariatric & Minimally Invasive Surgery Stanford School of Medicine Past-President, American Society of Metabolic and
More informationObesity Who is suitable for surgery? Professor Rob Andrews University of Exeter / Taunton NHS trust
Obesity Who is suitable for surgery? Professor Rob Andrews University of Exeter / Taunton NHS trust Investigator on BYBAND study Conflict of interest 3 Diet and Exercise studies (ACTID, EXTOD, STAMP2)
More informationControversies in Obesity Management Public Meeting
Controversies in Obesity Management Public Meeting July 14, 2015 1 Agenda Public Meeting Convened, Topic Overview 9:30 am Presentation of the Evidence and Economic Modeling, Q&A 9:35 10:40 am (Dr. Dan
More informationEndorsed by Executive Council June 17, American Society for Metabolic and Bariatric Surgery
Endorsed by Executive Council June 17, 2007 American Society for Metabolic and Bariatric Surgery POSITION STATEMENT ON SLEEVE GASTRECTOMY AS A BARIATRIC PROCEDURE Clinical Issues Committee Preamble. The
More informationBariatric Surgery. Options & Outcomes
Bariatric Surgery Options & Outcomes Obesity Obesity now leading cause of premature death & illness in Australia 67% of Australians are overweight or obese Australia 4 th fattest nation in OECD Obesity
More informationPolicy Specific Section: April 14, 1970 June 28, 2013
Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions
More informationBariatric surgery. KHALAJ A.R. M.D Obesity Clinic Mostafa Khomini Hospital Shahed University Tehran
Bariatric surgery KHALAJ A.R. M.D Obesity Clinic Mostafa Khomini Hospital Shahed University Tehran WWW.IRANOBESITY.COM Why Surgery? What is Indication of Surgery? What is ContraIndication of surgery? What
More informationThe Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do
1 The Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do Dr. Monali Misra, MD, FRCS(C), FACS Assistant Professor Department of Surgery, St. Joseph s Healthcare, McMaster University
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationUpdate on Diabetes Canadian Society of Internal Medicine Oct 11, 2018
https://www.australiawidefirstaid.com.au/what-is-diabetes/ Update on Diabetes Canadian Society of Internal Medicine Oct 11, 2018 Praveena Sivapalan MD, FRCPC Division of General Internal Medicine, University
More informationMid-term results of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy compared results of the SLEEVEPASS and SM-BOSS trials
Editorial Page 1 of 5 Mid-term results of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy compared results of the SLEEVEPASS and SM-BOSS trials David Benaiges 1,2,3, Elisenda
More informationReview Article Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m 2
Journal of Obesity Volume 2012, Article ID 147256, 9 pages doi:10.1155/2012/147256 Review Article Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m 2 Hideharu Shimizu, Poochong
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of implantation of a duodenal jejunal bypass sleeve for managing obesity Inserting
More informationBariatric Surgery for People with Diabetes and Morbid Obesity
Ontario Health Technology Assessment Series 2009; Vol. 9, No. 22 Bariatric Surgery for People with Diabetes and Morbid Obesity An Evidence-Based Analysis Presented to the Ontario Health Technology Advisory
More informationWei-Jei Lee, M.D., Ph.D. Dept. of Surg., Min-Sheng General Hospital, National Taiwan University, Taiwan
Metabolic Surgery in Asia Wei-Jei Lee, M.D., Ph.D. Dept. of Surg., Min-Sheng General Hospital, National Taiwan University, Taiwan Type 2 diabetes mellitus (T2DM) is now a global health priority. It was
More informationBradley J. Needleman, MD, FACS Associate Professor of Clinical Surgery
Bariatric Surgery: Current Status Bradley J. Needleman, MD, FACS Associate Professor of Clinical Surgery Director, Bariatric Surgery Program Center for Minimally Invasive Surgery The Ohio State University
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery
More informationCase Presentation: Morbidly Obese Adolescent. Daniel DeUgarte,, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program
Case Presentation: Morbidly Obese Adolescent Daniel DeUgarte,, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program R.A. 15y/o Adolescent Girl 138kg / 160.8cm 53.4 BMI Overweight since
More informationDiabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index <35 kg/m2
Diabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index
More informationObesity epidemic Pathophysiology of obesity and comorbidities Bariatric Surgery indications Multidisciplinary Team Treatment options Results
Surgical Considerations in the Treatment of Morbid Obesity Raymond J. Gagliardi, MD, FACS Director, Minimally i Invasive Surgery Associate Professor of Surgery Department of Surgery University of Kentucky
More informationA critical appraisal by an anesthesiologist. Marc Van de Velde Anesthesiology UZ Leuven KUL Belgium. Disclaimer.
Short- and dlongterm outcome after bariatric ti surgery: A critical appraisal by an anesthesiologist. Marc Van de Velde Anesthesiology UZ Leuven KUL Belgium Disclaimer. 1 Disclaimer. Limited experience
More informationENTRY CRITERIA: C. Approved Comorbidities: Diabetes
KAISER PERMANENTE OHIO BARIATRIC SURGERY (GASTROPLASTY) Methodology: Expert Opinion Issue Date: 12-05 Champion: Surgery Review Date: 4-10, 4-12 Key Stakeholders: Surgery, IM Depts. Next Update: 4-14 RELEVANCE:
More informationBariatric Care Center Outcomes Report
Bariatric Care Center 215 Outcomes Report Since my surgery, my life is happier; I am happier with myself. Lisa Mark, Weight Loss Surgery Patient 2 Bariatric Care Center Contents Surgical Procedure Volume
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationDisclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor
Sleeve Plus Options Disclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor Mederi - Speaker Novadaq - Advisory
More informationDiabetes Head To Toe May 31, Obesity in Canada. Six million Canadians are living with obesity
Medical & Surgical Options for the Bariatric Patient Michelle Mountain, RD, B.Sc Obesity in Canada 1 in 5 adults are obese Six million Canadians are living with obesity 1 in 10 children have clinical obesity
More informationDianne Kristine Joy Closa*, Armin Masbang, Dianne Shari Cabrera, Allan Dampil and Robert Mirasol
Cronicon OPEN ACCESS EC DIABETES AND METABOLIC RESEARCH Research Article Effects of Bariatric Surgery on Glucose Control, Weight Reduction and Disease Remission among Patients with Type 2 Diabetes Mellitus:
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationSubstantial Decrease in Comorbidity 5 Years After Gastric Bypass
Substantial Decrease in Comorbidity 5 Years After Gastric Bypass A Population-based Study From the Scandinavian Obesity Surgery Registry Sundbom, Magnus; Hedberg, Jakob; Marsk, Richard; Boman, Lars; Bylund,
More informationBariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients. Results of the STAMPEDE Trial
ariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic atients Results of the STAMEDE Trial R Schauer, SR Kashyap, K Wolski, SA rethauer, Kirwan, CE othier, S Thomas, Abood, SE Nissen and DL
More informationObesity and Bariatric Surgery Michel M. Murr, MD, FACS
Obesity and Bariatric Surgery Michel M. Murr, MD, FACS Director of Bariatric Center Chief of Surgery, TGH Professor of Surgery, USF Disclosure Covidien: educational grants Obesity and Bariatric Surgery
More informationLecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries
Bariatric Surgery What the PCP Needs to Know Mouna Abouamara Assistant Professor Internal Medicine James H Quillen College Of Medicine Lecture Goals Indications for bariatric Surgeries Different types
More informationChairman s Rounds, 02/15/2011
Chairman s Rounds, 02/15/2011 Edward Lipkin, MD Associate Professor, Department of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington Predictive factors in patient s
More informationSurgical Treatment of Obesity. 1. Understand who is an appropriate candidate for referral for surgical weight loss.
Surgical Treatment of Obesity Learning Objectives: 1. Understand who is an appropriate candidate for referral for surgical weight loss. 2. Appreciate impact of operative weight reduction to improve co-morbid
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationMetabolic Outcomes of Laparoscopic Diverted Sleeve Gastrectomy with Ileal Transposition (DSIT) in Obese Type 2 Diabetic Patients
OBES SURG (2015) 25:2018 2022 DOI 10.1007/s11695-015-1671-1 ORIGINAL CONTRIBUTIONS Metabolic Outcomes of Laparoscopic Diverted Sleeve Gastrectomy with Ileal Transposition (DSIT) in Obese Type 2 Diabetic
More informationMedical Policy Bariatric Surgery. Document Number: 042 Commercial and Qualified Health Plans MassHealth Authorization required X X
Medical Policy Bariatric Surgery Document Number: 042 Commercial and Qualified Health Plans MassHealth Authorization required X X No Prior Authorization Overview The purpose of this document is to describe
More informationPEDIATRIC OBESITY: ASSESSMENT, PREVENTION, & TREATMENT. Selma Feldman Witchel, MD Children s Hospital of Pittsburgh of UPMC
PEDIATRIC OBESITY: ASSESSMENT, PREVENTION, & TREATMENT Selma Feldman Witchel, MD Children s Hospital of Pittsburgh of UPMC disclosures Ilene Fennoy, MD, MPH Professor of Pediatrics Columbia University,
More informationMorbid Obesity A Curable Disease?
Morbid Obesity A Curable Disease? Piotr Gorecki, M.D. F.A.C.S. Associate Professor of Clinical Surgery Weill Medical College of Cornell University Chief of Laparoscopic Surgery New York Methodist Hospital
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationPredictors for Remission of Major Components of the Metabolic Syndrome After Biliopancreatic Diversion with Duodenal Switch (BPDDS)
DOI.7/s1169-12-77- CLINICAL RESEARCH Predictors for of Major Components of the Metabolic Syndrome After Biliopancreatic Diversion with Duodenal Switch (BPDDS) Villy Våge & Roy M. Nilsen & Arnold Berstad
More informationBariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient
Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;
More informationSleeve Gastrectomy Debate: Everyone Needs a Sleeve!!! Dana Portenier, MD Assistant Professor of Surgery Duke University Medical Center
Sleeve Gastrectomy Debate: Everyone Needs a Sleeve!!! Dana Portenier, MD Assistant Professor of Surgery Duke University Medical Center 1. Safety Two Year Excess Weight Loss Two Year Weight Loss and Mortality
More informationType 2 diabetes and metabolic surgery:
Type 2 diabetes and metabolic surgery: Shouldn't we call it again Surgery for Type 2 DM again bariatric? Is it Metabolic or Bariatric surgery? Josep Vidal Obesity Unit. Endocrinology and Nutrition Department
More informationGoals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management
The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity
More informationMetabolic Surgery for Type 2 Diabetes - Window into Pathophysiology-
Metabolic Surgery for Type 2 Diabetes - Window into Pathophysiology- Prof. Francesco Rubino, MD Chair of Bariatric and Metabolic Surgery King's College London London, UK September 15, 2014 DISCLOSURE SLIDE
More informationSLEEVEPASS RCT: SLEEVE vs. bypass 5-year results
SLEEVEPASS RCT: SLEEVE vs. bypass 5-year results Thun 30.11.2018 Paulina Salminen MD, PhD, Professor of Surgery Turku University Hospital, Turku, Finland SLEEVEPASS trial PI Disclosures Lecture fees: Merck,
More informationMedicare Part C Medical Coverage Policy
Morbid Obesity Surgery Origination: June 30, 1988 Review Date: October 18, 2017 Next Review: October, 2019 Medicare Part C Medical Coverage Policy DESCRIPTION OF PROCEDURE OR SERVICE Bariatric surgery
More informationGlycemic Control in Diabetic Patients after Bariatric Surgery
Obesity Surgery, 14, 1051-1055 Glycemic Control in Diabetic Patients after Bariatric Surgery Maria de Fátima Haueisen Sander Diniz, MD 1 ; Marco Túlio Costa Diniz, PhD 2 ; Soraya Rodrigues Almeida Sanches,
More informationType 2 diabetes remission following gastric bypass: does diarem stand the test of time?
Surg Endosc (2017) 31:538 542 DOI 10.1007/s00464-016-4964-0 and Other Interventional Techniques Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? J. Hunter Mehaffey
More informationOBESITY:Pharmacotherapy Vs Surgery
OBESITY:Pharmacotherapy Vs Surgery Dr. Ranajit Sen Chowdhury Associate Professor Department of Medicine Sir Salimullah Medical College & Mitford Hospital. 1 Historical Perspective Paleolithic Era > 25,000
More informationWeight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity
3/30/12 Weight Loss Surgery What Every GI Nurse Needs to Know Kenneth A Cooper, D.O. March 31, 2012 Outline Define Morbid Obesity & its Medical Consequences Treatments for Obesity Bariatric (Weight-loss)
More information